Permeon Biologics

Cequent Pharmaceuticals, a privately held biopharmaceutical company based in Cambridge, Massachusetts, is at the forefront of developing novel therapeutics aimed at preventing and treating a variety of human diseases, including inflammatory diseases and cancer. Established in 2006, the company leverages its proprietary TransKingdom RNA interference (tkRNAi) technology to target specific disease-causing genes safely and effectively using non-pathogenic bacteria as delivery vehicles. The tkRNAi platform enables the development of drug candidates that can silence one or more cellular genes simultaneously, offering a powerful alternative to traditional small molecules and monoclonal antibodies. With its foundation rooted in groundbreaking scientific research from the Institut Pasteur in Paris and Beth Israel Deaconess Medical Center at Harvard Medical School, Cequent is poised to make significant advancements in the biopharmaceutical landscape. Generated from the website

Avrobio Liquors, located in Las Palmas, offers specialized consultancy services tailored to a variety of client needs. Their expert team provides support across multiple areas, ensuring comprehensive solutions for all inquiries. The Ninja Avrobio Team prides itself on delivering the best liquor services in the region. With a commitment to excellence, they are prepared to assist clients with their unique requirements in the liquor industry. Generated from the website

Arkuda is comprised of passionate and experienced team members who are dedicated to improving the lives of people affected by neurodegenerative disease. Armed with deep expertise in biology and the ab